Quebec must act immediately to lower its colon cancer screening age to 45, health advocates say, following Ontario’s landmark decision this week to expand eligibility for all residents aged 45 and older. The move, announced by Ontario’s Ministry of Health, aligns with growing global consensus that earlier screening saves lives, as rising incidence rates among younger adults—particularly in North America—demand proactive measures. According to the Canadian Cancer Society, colorectal cancer cases among Canadians under 50 have nearly doubled since the 1990s, yet Quebec’s current screening program still begins at 50—a gap experts warn is costing lives.
Ontario’s shift, effective immediately, marks the first provincial overhaul of Canada’s national colorectal cancer screening guidelines, which previously recommended starting at 50. The province’s decision comes after a 2023 report from the Ontario Health Cancer Screening Committee found that 1 in 4 new colorectal cancer diagnoses now occur in individuals under 50, with survival rates dropping by nearly 20% when detected late. “This isn’t just about catching cancer earlier—it’s about preventing it,” said Dr. David Hwang, a gastrointestinal oncologist at Sunnybrook Health Sciences Centre in Toronto. “The data is clear: younger patients present with more aggressive tumors, and we’re losing too many preventable deaths.”
Quebec’s delay in adopting similar measures has left public health officials and patient groups frustrated. While Ontario’s program now covers 1.5 million additional residents, Quebec’s current screening protocol remains unchanged, despite the province recording a 30% increase in colorectal cancer cases among 40–49-year-olds since 2018, per Institut national de santé publique du Québec (INSPQ) data. “Quebec cannot afford to wait,” said Marie-Claude Bourgeois, president of the Canadian Cancer Society’s Quebec chapter. “We’ve seen the same trends here—younger patients are being diagnosed at later stages, and that’s a death sentence we can prevent.”
Why Ontario’s Move Matters: The Science Behind the Shift
Ontario’s decision is rooted in decades of evolving research. A 2021 study published in The Lancet Gastroenterology & Hepatology found that colorectal cancer incidence in individuals aged 20–39 rose by 2% annually from 1994–2019, while mortality rates for early-onset cases remain 30% higher than for those diagnosed after 50. The World Health Organization (WHO) now recommends screening begin at 45 in countries with high cancer burdens, citing genetic, lifestyle, and environmental factors—including diet, obesity, and sedentary behavior—that accelerate risk in younger populations.
Quebec’s hesitation stems partly from logistical concerns. The province’s existing screening program, which relies on fecal immunochemical tests (FIT) mailed to eligible residents, faces capacity strains even at its current scale. Expanding to 45-year-olds would add an estimated 300,000 new participants annually, requiring additional funding, staff, and lab infrastructure. “The challenge isn’t just medical—it’s systemic,” said Dr. Sophie Lalonde, a public health specialist at Université Laval. “But the cost of inaction is far greater. We’re talking about thousands of preventable deaths over the next decade.”
Key Takeaway: Ontario’s expansion reflects a global trend—12 U.S. states and the American Cancer Society now recommend starting screening at 45, while the UK’s National Health Service lowered its threshold to 50 in 2019. Quebec’s delay risks leaving its population vulnerable during a critical window for early detection.
Quebec’s Stalled Action: What’s Holding It Back?
While Ontario acted swiftly, Quebec’s health ministry has not announced plans to follow suit. Sources close to the Ministère de la Santé et des Services sociaux (MSSS) cite “ongoing review” of provincial data, though no timeline has been set. Critics argue the delay reflects political inertia rather than scientific caution. “This isn’t about evidence—it’s about bureaucracy,” said Bourgeois. “Other provinces are moving; Quebec is stuck in the past.”
One barrier is Quebec’s historical reliance on centralized screening, which contrasts with Ontario’s decentralized approach. Ontario’s program allows for regional flexibility, enabling faster adjustments based on local incidence rates. Quebec’s system, by comparison, requires provincial approval for any changes—a process that can take years. “The red tape is killing people,” said Dr. Hwang. “We need a system that can adapt in real time, not one that moves at the speed of government.”
Another factor is funding. Ontario’s expansion was supported by a $120 million allocation in its 2024 budget, earmarked for screening infrastructure and public awareness campaigns. Quebec’s 2024 budget did not include similar provisions, though the MSSS has not ruled out future funding requests. Without dedicated resources, experts warn, the province risks overburdening its already strained healthcare system.
What Happens Next? Quebec’s Options and the Path Forward
Quebec has three clear paths forward, each with distinct implications:
- Immediate adoption: Follow Ontario’s lead by lowering the screening age to 45, with targeted funding for expanded testing and public education. This would require legislative approval and a rapid mobilization of resources.
- Phased rollout: Gradually expand eligibility, starting with high-risk groups (e.g., those with a family history of colorectal cancer or inflammatory bowel disease) before lowering the age for the general population. This approach, favored by some public health experts, would mitigate logistical challenges.
- No change: Maintain the current threshold of 50, citing insufficient evidence or budget constraints. This option carries the highest risk, given the rising incidence rates among younger Quebecers.
Public pressure is mounting. A petition launched by the Canadian Cancer Society has already garnered over 50,000 signatures demanding Quebec act within 90 days. Meanwhile, the Canadian Colorectal Cancer Association has called for a national standard, urging all provinces to align with Ontario’s new guidelines.
The next critical checkpoint is Quebec’s annual public health report, due in late September. If the province does not announce a timeline by then, advocates warn they will escalate their campaign, including legal challenges under Canada’s Canada Health Act, which mandates equitable access to medically necessary services.
How to Get Screened: A Step-by-Step Guide for Quebecers
For Quebecers concerned about their risk, here’s what to do now:
- Assess your risk: Colorectal cancer risk increases with age, family history, obesity, smoking, or a history of inflammatory bowel disease. Use the Canadian Cancer Society’s risk assessment tool to evaluate your eligibility.
- Talk to your doctor: If you’re under 50 but have symptoms (e.g., unexplained weight loss, blood in stool, persistent abdominal pain), request a referral for a colonoscopy or FIT test. Quebec’s screening program covers tests for those aged 50–74, but private testing is an option for higher-risk individuals.
- Advocate for change: Contact your local MNA (Member of the National Assembly) or the MSSS to demand action. Sample letters and petitions are available via Cancer Canada and the Colorectal Cancer Association.
- Stay informed: Follow updates from Quebec’s screening program and Ontario’s expanded guidelines for potential policy shifts.
FAQ: Your Questions About Colon Cancer Screening
Q: Is colon cancer really increasing in younger people?
A: Yes. Studies show colorectal cancer rates in Canadians under 50 have risen by nearly 100% since the 1990s, according to the Canadian Cancer Society. The cause is multifactorial, including diet, obesity, and genetic predispositions.
Q: Are there symptoms I should watch for?
A: Common signs include blood in stool, persistent abdominal pain, unintended weight loss, or changes in bowel habits. If you experience these, consult a doctor—early detection saves lives.
Q: Why does Quebec’s program start at 50?
A: Quebec’s current guidelines follow the national recommendations set in 2010, which were based on older data. Ontario’s update reflects newer evidence, but Quebec has not yet revised its policy.
Q: What’s the difference between a colonoscopy and a FIT test?
A: A colonoscopy is a direct exam of the colon using a scope, while a FIT test checks for hidden blood in stool. Colonoscopies are more thorough but invasive; FIT tests are non-invasive and used for initial screening.
Q: Will Ontario’s change affect Quebec’s screening program?
A: Not directly, but it increases pressure on Quebec to align. Ontario’s move is a signal that the scientific consensus has shifted—Quebec’s delay could isolate it from national and international standards.
Q: How can I push for change in Quebec?
A: Join advocacy groups like the Canadian Cancer Society or Colorectal Cancer Association, contact your MNA, and share your story. Public demand has forced policy changes before—this could be the next case.
Next Steps: Quebec’s Ministry of Health has not set a timeline for reviewing its screening program, but advocates expect an announcement by late 2024. In the meantime, individuals concerned about their risk should consult their healthcare provider about private testing options or participate in Quebec’s existing program if eligible.
Your Turn: Has Quebec’s delay affected your health decisions? Share your experiences in the comments below—or help amplify the call for change by sharing this article with friends and family. Early detection saves lives, and the time to act is now.